QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (108) Citing Articles via Google Scholar Google Scholar Articles by Molina-Holgado, E. Articles by Guaza, C. Search for Related Content PubMed PubMed Citation Articles by Molina-Holgado, E. Articles by Guaza, C. Pubmed/NCBI databases Medline Plus Health Information Stem Cells

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 15, 2002, 22(22):9742-9753

Cannabinoids Promote Oligodendrocyte Progenitor Survival: Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase/Akt Signaling

Eduardo Molina-Holgado¹, José M. Vela², Angel Arévalo-Martín¹, Guillermina Almazán³, Francisco Molina-Holgado⁴, José Borrell¹, and Carmen Guaza¹

¹ Department of Neural Plasticity, Cajal Institute, Consejo Superior de Investigaciones Científicas, 28002 Madrid, Spain, ² Department of Cellular Biology and Physiology, Histology Unit, Autònoma University of Barcelona, 08193 Bellaterra, Barcelona, Spain, ³ Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada H3G 1H6, and ⁴ Neurology Unit, Department of Clinical Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom CB3 OES

Cannabinoids exert pleiotropic actions in the CNS, including the inhibition of inflammatory responses and the enhancement of neuronal survival after injury. Although cannabinoid receptors are distributed widely in brain, their presence has not been investigated previously in oligodendrocytes. This study examined the expression of cannabinoid type 1 (CB1) receptors in rat oligodendrocytes in vivo and in culture and explored their biological function. Expression of CB1 receptors by oligodendrocytes was demonstrated immunocytochemically in postnatal and in adult white matter as well as in oligodendrocyte cultures. Reverse transcription-PCR and Western blotting further confirmed the presence of CB1 receptors. Oligodendrocyte progenitors undergo apoptosis with the withdrawal of trophic support, as determined by TUNEL assay and caspase-3 activation, and both the selective CB1 agonist arachidonyl-2'-chloroethylamide/(all Z)-N-(2-cycloethyl)-5,8,11,14-eicosatetraenamide (ACEA) and the nonselective cannabinoid agonists HU210 and (+)-Win-55212-2 enhanced cell survival. To investigate intracellular signaling involved in cannabinoid protection, we focused on the phosphatidylinositol-3 kinase (PI3K)/Akt pathway. HU210, (+)-Win-55212-2, and ACEA elicited a time-dependent phosphorylation of Akt. Pertussis toxin abolished Akt activation, indicating the involvement of G_i/G_o-protein-coupled receptors. The CB1 receptor antagonist SR141716A partially inhibited Akt phosphorylation in response to HU210 and (+)-Win-55212-2 and abolished the effects of ACEA. Trophic support deprivation downregulated Akt activity, and cannabinoids recovered phospho-Akt levels. Inhibition of PI3K abrogated the survival action and the recovery of Akt activity in response to cannabinoids. SR141716A prevented only the protection conferred by ACEA. Nevertheless, SR141716A and the selective CB2 receptor antagonist SR144528 in combination inhibited the prosurvival action of HU210, which is in accordance with the finding of CB2 receptor expression by oligodendroglial cells. These data identify oligodendrocytes as potential targets of cannabinoid action in the CNS.

Key words: apoptosis; oligodendrocytes; Akt; glycogen synthase kinase 3; CB1 receptors; CB2 receptors

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/22229742-12$05.00/0

This article has been cited by other articles:

				N. E. Freeman-Anderson, T. G. Pickle, C. D. Netherland, A. Bales, N. E. Buckley, and D. P. Thewke Cannabinoid (CB2) receptor deficiency reduces the susceptibility of macrophages to oxidized LDL/oxysterol-induced apoptosis J. Lipid Res., November 1, 2008; 49(11): 2338 - 2346. [Abstract] [Full Text] [PDF]

				J. Palazuelos, N. Davoust, B. Julien, E. Hatterer, T. Aguado, R. Mechoulam, C. Benito, J. Romero, A. Silva, M. Guzman, et al. The CB2 Cannabinoid Receptor Controls Myeloid Progenitor Trafficking: INVOLVEMENT IN THE PATHOGENESIS OF AN ANIMAL MODEL OF MULTIPLE SCLEROSIS J. Biol. Chem., May 9, 2008; 283(19): 13320 - 13329. [Abstract] [Full Text] [PDF]

				D. A. Karanian, S. L. Karim, J. T. Wood, J. S. Williams, S. Lin, A. Makriyannis, and B. A. Bahr Endocannabinoid Enhancement Protects against Kainic Acid-Induced Seizures and Associated Brain Damage J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1059 - 1066. [Abstract] [Full Text] [PDF]

				I. Galve-Roperh, T. Aguado, J. Palazuelos, and M. Guzman The Endocannabinoid System and Neurogenesis in Health and Disease Neuroscientist, April 1, 2007; 13(2): 109 - 114. [Abstract] [PDF]

				C. Benito, J. P. Romero, R. M. Tolon, D. Clemente, F. Docagne, C. J. Hillard, C. Guaza, and J. Romero Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis J. Neurosci., February 28, 2007; 27(9): 2396 - 2402. [Abstract] [Full Text] [PDF]

				C. Blazquez, A. Carracedo, L. Barrado, P. J. Real, J. L. Fernandez-Luna, G. Velasco, M. Malumbres, and M. Guzman Cannabinoid receptors as novel targets for the treatment of melanoma FASEB J, December 1, 2006; 20(14): 2633 - 2635. [Abstract] [Full Text] [PDF]

				J. Palazuelos, T. Aguado, A. Egia, R. Mechoulam, M. Guzman, and I. Galve-Roperh Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation FASEB J, November 1, 2006; 20(13): 2405 - 2407. [Abstract] [Full Text] [PDF]

				S. H. Kim, S. J. Won, X. O. Mao, C. Ledent, K. Jin, and D. A. Greenberg Role for Neuronal Nitric-Oxide Synthase in Cannabinoid-Induced Neurogenesis J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 150 - 154. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]

				Q.-L. Cui, W.-H. Zheng, R. Quirion, and G. Almazan Inhibition of Src-like Kinases Reveals Akt-dependent and -independent Pathways in Insulin-like Growth Factor I-mediated Oligodendrocyte Progenitor Survival J. Biol. Chem., March 11, 2005; 280(10): 8918 - 8928. [Abstract] [Full Text] [PDF]

				B. G. Ramirez, C. Blazquez, T. G. del Pulgar, M. Guzman, and M. L. de Ceballos Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation J. Neurosci., February 23, 2005; 25(8): 1904 - 1913. [Abstract] [Full Text] [PDF]

				I. Tegeder and G. Geisslinger Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications Pharmacol. Rev., September 1, 2004; 56(3): 351 - 369. [Abstract] [Full Text] [PDF]

				K. Jin, L. Xie, S. H. Kim, S. Parmentier-Batteur, Y. Sun, X. O. Mao, J. Childs, and D. A. Greenberg Defective Adult Neurogenesis in CB1 Cannabinoid Receptor Knockout Mice Mol. Pharmacol., August 1, 2004; 66(2): 204 - 208. [Abstract] [Full Text] [PDF]

				A. Arevalo-Martin, J. M. Vela, E. Molina-Holgado, J. Borrell, and C. Guaza Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis J. Neurosci., April 1, 2003; 23(7): 2511 - 2516. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help